Select for export Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(16)30065-7 PubMed 27210031 Copy citation Copy BibTeX The Lancet Psychiatry 2016-05-16 Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114565144 PubMed 25586396 Copy citation Copy BibTeX Journal of Psychopharmacology 2015-01-12 Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Europe PMC Published psilocybin AddictionMechanism of ActionReceptor Pharmacology Qualitative Study More
Select for export Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study No abstract availability was recorded for this entry. Details DOI 10.1016/j.drugalcdep.2014.02.200 Copy citation Copy BibTeX Drug and Alcohol Dependence 2014-06-06 Albert Garcia-Romeu, Matthew W. Johnson, Roland R. Griffiths OpenAlex Published psilocybin AddictionMechanism of ActionRandomized Controlled Trial Randomized Controlled Trial More
Select for export A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3109/00952990.2013.811513 PubMed 23968172 Copy citation Copy BibTeX The American Journal of Drug and Alcohol Abuse 2013-08-31 Burdick BV, Adinoff B. Europe PMC Published psilocybin AddictionMystical ExperienceClinical Trial Randomized Controlled Trial More
Select for export Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0014074 PubMed 21152030 Copy citation Copy BibTeX PLoS ONE 2010-12-01 Matthew J. Baggott, Jennifer D. Siegrist, Gantt P. Galloway, Lynn C. Robertson, Jeremy Coyle, John Mendelson OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Randomized Controlled Trial More
Select for export Determining the subjective effects of TFMPP in human males. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-010-1911-y PubMed 20552171 Copy citation Copy BibTeX Unknown journal 2010-06-15 Jan RK, Lin JC, Lee H, Sheridan JL, Kydd RR, Kirk IJ Europe PMC Published psilocybin AnxietyAddictionReceptor Pharmacology Observational Study More
Select for export Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-002-1237-5 PubMed 12474114 Copy citation Copy BibTeX Unknown journal 2002-10-11 Riba J, Rodríguez-Fornells A, Barbanoj MJ. Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyClinical Trial Clinical Trial More
